期刊文献+

Prognostic Significance of Lymphovascular Invasion in Bladder Cancer after Surgical Resection:A Meta-analysis 被引量:6

Prognostic Significance of Lymphovascular Invasion in Bladder Cancer after Surgical Resection:A Meta-analysis
下载PDF
导出
摘要 Bladder cancer remains a commonly diagnosed malignancy worldwide,bringing huge economic burden and high morbidity for patients. Assessment of prognostic significance of lymphovascular invasion(LVI) is a critical issue in the surgical management of bladder cancer after transurethral resection or radical cystectomy. A systematic search of Pub Med,Embase and Cochrane Library was performed up to Oct 10,2014 to identify eligible studies. Outcomes of interest were collected from studies comparing overall survival(OS),cancer specific survival(CSS) and recurrence free survival(RFS) in patients with the LVI. Results of studies were pooled,and combined hazard ratios(HRs) with corresponding 95% confidence intervals(CIs) for survival were used as the effect size estimation. Funnel plots were done to show the publication bias,while the forest plots and subgroup analyses were used to limit the heterogeneity. A total of 20 studies(10 663 patients) met the eligibility criteria and were included for this meta-analysis. Our pooled results showed that there were significant differences in OS(pooled HR,1.71; 95%CI,1.52–1.92; P〈0.00001),CSS(pooled HR,2.25; 95% CI,1.80–2.81; P〈0.00001) and RFS(pooled HR,1.91; 95% CI,1.57–2.32; P〈0.00001) between the patients with LVI and the patients without LVI. There were significant heterogeneities observed in the studies concerning the relationship between LVI and CSS,RFS. There was no clear evidence of publication bias. When tumor stage was beyond T3,LVI lost its predictive value for CSS and RFS. For the patients who had negative lymph nodes,LVI was still an adverse predictor. Our pooled results demonstrate that LVI indicates poor prognosis of patients with bladder cancer after surgical procedures,and it can be of particular importance in clinical practice. However,these results need to be further confirmed by more adequately designed prospective studies. Bladder cancer remains a commonly diagnosed malignancy worldwide,bringing huge economic burden and high morbidity for patients. Assessment of prognostic significance of lymphovascular invasion(LVI) is a critical issue in the surgical management of bladder cancer after transurethral resection or radical cystectomy. A systematic search of Pub Med,Embase and Cochrane Library was performed up to Oct 10,2014 to identify eligible studies. Outcomes of interest were collected from studies comparing overall survival(OS),cancer specific survival(CSS) and recurrence free survival(RFS) in patients with the LVI. Results of studies were pooled,and combined hazard ratios(HRs) with corresponding 95% confidence intervals(CIs) for survival were used as the effect size estimation. Funnel plots were done to show the publication bias,while the forest plots and subgroup analyses were used to limit the heterogeneity. A total of 20 studies(10 663 patients) met the eligibility criteria and were included for this meta-analysis. Our pooled results showed that there were significant differences in OS(pooled HR,1.71; 95%CI,1.52–1.92; P〈0.00001),CSS(pooled HR,2.25; 95% CI,1.80–2.81; P〈0.00001) and RFS(pooled HR,1.91; 95% CI,1.57–2.32; P〈0.00001) between the patients with LVI and the patients without LVI. There were significant heterogeneities observed in the studies concerning the relationship between LVI and CSS,RFS. There was no clear evidence of publication bias. When tumor stage was beyond T3,LVI lost its predictive value for CSS and RFS. For the patients who had negative lymph nodes,LVI was still an adverse predictor. Our pooled results demonstrate that LVI indicates poor prognosis of patients with bladder cancer after surgical procedures,and it can be of particular importance in clinical practice. However,these results need to be further confirmed by more adequately designed prospective studies.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2015年第5期646-655,共10页 华中科技大学学报(医学英德文版)
基金 supported by the National Natural Science Foundation of China(Nos.31072238,31172441,31372562,81170650) National Major Scientific and Technological Special Project for Significant New Drugs Development(No.2012ZX09303018)
关键词 bladder recurrence malignancy cystectomy transurethral TURBT invasion prognosis confidence subgroup bladder recurrence malignancy cystectomy transurethral TURBT invasion prognosis confidence subgroup
  • 相关文献

参考文献35

  • 1Griffiths TR; ACTION ON BLADDER C. Current perspectives in bladder cancer management. Int J Clin Pratt, 2013,67(5):435-448.
  • 2Faba OR, Palou J, Breda A, et al. High-risk snon-muscle- invasive bladder cancer: update for a better identificationand treatment. World J Urol, 2012,30(6):833-840.
  • 3Gakis G; Efstathiou J, Lerner SP, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle- invasive urothelial carcinoma of the bladder. Eur Urol, 2013,63(1):45-57.
  • 4Resnick MJ, Bassett JC, Clark PE. Management of superficial and muscle-invasive urothelial cancers of the bladder. Curr Opin Oncol, 2013,25(3):281-288.
  • 5Kondo T, Tanabe K. Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract. Int J Urol, 2012,19(8):710-721.
  • 6Steinberg CN, Bellmun J, Sonpavde G~ et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma--neoadjuvant and adjuvant settings. Eur Urol, 2013,63(1):58-66.
  • 7Chang DW, Gu J, Wu X. Germline prognostic markers for urinary bladder cancer: obstacles and opportunities. Urol Oncol, 2012,30(4):524-532.
  • 8Frantzi M, Makridakis M, Vlahou A. Biomarkers for bladder cancer aggressiveness. Curr Opin Urol, 2012,22(5):390-396.
  • 9Gakis C~ Schwentner C, Todenhofer T~ et al. Current status of molecular markers for prognostication and outcome in invasive bladder cancer. BJU Int, 2012,110(2):233-237.
  • 10Rink M, Cha EK, Green D, et al. Biomolecular predictors of urothelial cancer behavior and treatment outcomes. Curr Urol Rep, 2012,13(2):122-135.

同被引文献22

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部